Chrononutrition in Cardiometabolic Health.
Vasiliki KatsiIlias P PapakonstantinouStergios SoulaidopoulosNiki KatsikiKonstantinos TsioufisPublished in: Journal of clinical medicine (2022)
In recent years, a healthy balanced diet together with weight reduction has risen to the forefront of minimizing the impact of cardiovascular disease. There is evidence that metabolic processes present circadian rhythmicity. Moreover, the timing of food consumption exerts a powerful influence on circadian rhythms. In this context, the subject of chrononutrition, described as the alignment of timing of food intake to the rhythms imposed by the circadian clock, has attracted considerable interest for possible beneficial effects on cardiovascular health. Current human studies suggest that chrononutrition-based dietary interventions could reduce the risk for cardiovascular disease by improving weight control, hypertension, dyslipidemia, and diabetes. However, meta-analysis of randomized control trials in this topic present varying and somehow conflicting results. Even the traditional association of breakfast skipping with adverse cardiovascular outcomes is nowadays controversial. Therefore, long-term and fairly consistent studies on the effect of chrononutrition on cardiovascular outcomes are needed. The purpose of this review is to provide concise evidence of the most recent literature involving the effects of chrononutrition and the specific chrononutrition-based dietary interventions, in particular time-restricted eating, on body weight and other cardiovascular disease risk factors.
Keyphrases
- cardiovascular disease
- body weight
- physical activity
- weight loss
- type diabetes
- risk factors
- endothelial cells
- healthcare
- body mass index
- cardiovascular risk factors
- cardiovascular events
- systematic review
- blood pressure
- mental health
- case control
- human health
- emergency department
- metabolic syndrome
- phase iii
- randomized controlled trial
- risk assessment
- induced pluripotent stem cells
- climate change
- coronary artery disease
- health promotion
- phase ii